: Collection of Race and Ethnicity Data in Clinical Trials. The ostensible purpose of both of these guidelines is to promote more … efficient and economical development of new pharmaceutical interventions. Underlying both Guidances is a presumption that race … implicitly cast race and ethnicity as obstacles to be managed and overcome in the course of getting new drugs to global markets …

Inequality is a burning issue in our society but plays only a limited rule in the design of regulations. This article … existing system that promote inequality: the controversial practice of using uniform valuations of life and health, regardless … of income; and the use of disparate impact analysis in rulemaking. Rather than focusing on arguments for using regulation …

The overwhelming majority of biological scientists agree that there is no such thing as race among modern humans. Yet …, scientists regularly deploy race in their studies, and federal laws and regulations currently mandate the use of racial … synonymous with invalidation — does not offer a particularly useful way to think about the use of race in research. It offers no …

of medical research. I assess law reform options that have been proposed in the RES context, before considering the …

paper argues that the ‘race to AI' also brings forth a ‘race to AI regulation'. After discussing the regulatory toolbox for … countries and regions are explicitly taking part in a ‘race to AI'. Yet the increased visibility of the technology's risks has … led to ever-louder calls for regulators to look beyond the benefits, and also secure appropriate regulation to ensure AI …

The upswing in finance over the past several decades has led to rising inequality, but do downswings in finance lead to … a symmetric decline in inequality? In this paper, we analyze the asymmetry of the effect of ups and downs in financial … markets, as well as the effect of increased capital requirements and the bonus cap on national earnings inequality. We use …